You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

PACLitaxel

( pack-li-TAX-ell )
Funding:
New Drug Funding Program
  • Paclitaxel - Recurrent - Uterine Papillary Serous Carcinoma (UPSC)
  • Paclitaxel - Neoadjuvant Treatment for Non-Metastatic Breast Cancer
  • Paclitaxel - Adjuvant Treatment for Breast Cancer
  • Paclitaxel - Metastatic Breast Cancer
  • Paclitaxel - First Line - Uterine Papillary Serous Carcinoma (UPSC)
  • Paclitaxel - Non-Small Cell Lung Cancer (NSCLC)
  • Paclitaxel in Combination with Platinum - Recurrent - Advanced Ovarian Fallopian Tube or Primary Peritoneal Carcinoma
  • Paclitaxel - Single Agent Treatment of Platinum Sensitive Ovarian Fallopian Tube or Primary Peritoneal Cancer
  • Paclitaxel in Combination with Platinum - First Line - Advanced Ovarian Fallopian Tube or Primary Peritoneal Carcinoma
Other Name(s): Taxol® (multiple brands available)
Appearance: Clear solution mixed into larger bags of fluids

You might also be interested in